Differential expression of centrosomal proteins at different stages of human glioma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Loh, Joon Khim ^a,c   Lieu, Ann Shung ^a   Chou, Chia Hua ^d   Lin, Fang Yi ^d   Wu, Chia Hung ^d   Howng, Sheng Long ^a   Chio, Chung Ching ^b   Hong, Yi Ren ^a,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; AURORA B KINASE; CENTRIN 1; CENTRIN 2; GAMMA TUBULIN; MESSENGER RNA; NINEIN PROTEIN; NUCLEAR PROTEIN; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; MICROTUBULE PROTEIN;

ARTICLE; CANCER STAGING; CELL CYCLE REGULATION; CELLULAR DISTRIBUTION; CENTRIOLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MITOSIS; NUCLEAR SIZE; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADULT; AGED; BRAIN TUMOR; CASE CONTROL STUDY; CENTROSOME; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR CELL LINE;

ADULT; AGED; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CENTROSOME; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, FLUORESCENCE; MICROTUBULE PROTEINS; MIDDLE AGED; MITOSIS; NEOPLASM STAGING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953200264     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-268     Document Type: Article

References (33)

1. Lefranc F, Rynkowski M, DeWitte O, Kiss R. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg 2009, 34:3-35. full_text, 19368079.
2. Wang Q, Hirohashi Y, Furuuchi K, Zhao H, Liu Q, Zhang H, Murali R, Berezov A, Du X, Li B, Greene MI. The centrosome in normal and transformed cells. DNA Cell Biol 2004, 23:475-89. 10.1089/1044549041562276, 15307950.
3. Coumar MS, Cheung CH, Chang JY, Hsieh HP. Advances in Aurora kinase inhibitor patents. Expert Opin Ther Pat 2009, 19:321-56. 10.1517/13543770802646949, 19441907.
4. Cheung CH, Coumar MS, Hsieh HP, Chang JY. Aurora kinase inhibitors in preclinical and clinical testing. Expert Opin Investig Drugs 2009, 18:379-98. 10.1517/13543780902806392, 19335272.
5. Li JJ, Li SA. Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis. Pharmacol Ther 2006, 111:974-84. 10.1016/j.pharmthera.2006.02.006, 16603252.
6. Privette LM, Petty EM. CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis. Transl Oncol 2008, 1:57-64. 2510817, 18633460.
7. Cheng TS, Hsiao YL, Lin CC, Hsu CM, Chang MS, Lee CI, Yu RC, Huang CY, Howng SL, Hong YR. hNinein is required for targeting spindle-associated protein Astrin to the centrosome during the S and G2 phases. Exp Cell Res 2007, 313:1710-21. 10.1016/j.yexcr.2007.02.023, 17383637.
8. Errabolu R, Sanders MA, Salisbury JL. Cloning of a cDNA encoding human centrin, an EF-hand protein of centrosomes and mitotic spindle poles. J Cell Sci 1994, 107:9-16.
9. Dietzmann K, Kirches E, von B, Jachau K, Mawrin C. Increased human polo-like kinase-1 expression in gliomas. J Neurooncol 2001, 53:1-11. 10.1023/A:1011808200978, 11678424.
10. Roymans D, Vissenberg K, De Jonghe C, Willems R, Engler G, Kimura N, Grobben B, Claes P, Verbelen JP, Van Broeckhoven C, Slegers H. Identification of the tumor metastasis suppressor Nm23-H1/Nm23-R1 as a constituent of the centrosome. Exp Cell Res 2001, 262:145-53. 10.1006/excr.2000.5087, 11139339.
11. Reichardt W, Jung V, Brunner C, Klein A, Wemmert S, Romeike BF, Zang KD, Urbschat S. The putative serine/threonine kinase gene STK15 on chromosome 20 q13.2 is amplified in human gliomas. Oncol Rep 2003, 10:1275-9.
12. Klein A, Reichardt W, Jung V, Zang KD, Meese E, Urbschat S. Overexpression and amplification of STK15 in human gliomas. Int J Oncol 2004, 25:1789-94.
13. Katsetos CD, Reddy G, Dráberová E, Smejkalová B, Del Valle L, Ashraf Q, Tadevosyan A, Yelin K, Maraziotis T, Mishra OP, Mörk S, Legido A, Nissanov J, Baas PW, de Chadarévian JP, Dráber P. Altered cellular distribution and subcellular sorting of gamma-tubulin in diffuse astrocytic gliomas and human glioblastoma cell lines. J Neuropathol Exp Neurol 2006, 65:465-77. 10.1097/01.jnen.0000229235.20995.6e, 16772870.
14. Saito T, Hama S, Izumi H, Yamasaki F, Kajiwara Y, Matsuura S, Morishima K, Hidaka T, Shrestha P, Sugiyama K, Kurisu K. Centrosome amplification induced by survivin suppression enhances both chromosome instability and radiosensitivity in glioma cells. Br J Cancer 2008, 98:345-55. 10.1038/sj.bjc.6604160, 2361434, 18195712.
15. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, Hoang-Xuan K, El Hallani S, Idbaih A, Zelenika D, Andersson U, Henriksson R, Bergenheim AT, Feychting M, Lönn S, Ahlbom A, Schramm J, Linnebank M, Hemminki K, Kumar R, Hepworth SJ, Price A, Armstrong G, Liu Y, Gu X, Yu R, Lau C, Schoemaker M, Muir K, Swerdlow A, Lathrop M, Bondy M, Houlston RS. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 2009, 41:899-904. 10.1038/ng.407, 19578367.
16. Wrensch M, Jenkins RB, Chang JS, Yeh RF, Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, Giannini C, Halder C, Kollmeyer TM, Kosel ML, LaChance DH, McCoy L, O'Neill BP, Patoka J, Pico AR, Prados M, Quesenberry C, Rice T, Rynearson AL, Smirnov I, Tihan T, Wiemels J, Yang P, Wiencke JK. Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 2009, 41:905-8. 10.1038/ng.408, 19578366.
17. Zhang W, Wang J, Liu SJ, Hua W, Xin XY. Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients. Acta Obstet Gynecol Scand 2009, 88:521-7. 10.1080/00016340902835927, 19306133.
18. Wang R, Wang JH, Chu XY, Geng HC, Chen LB. Expression of STK15 mRNA in hepatocellular carcinoma and its prognostic significance. Clin Biochem 2009, 42:641-7. 10.1016/j.clinbiochem.2009.01.023, 19232520.
19. Mendiola M, Barriuso J, Mariño-Enríquez A, Redondo A, Domínguez-Cáceres A, Hernández-Cortés G, Pérez-Fernández E, Sánchez-Navarro I, Vara JA, Suárez A, Espinosa E, González-Barón M, Palacios J, Hardisson D. Aurora kinases as prognostic biomarkers in ovarian carcinoma. Hum Pathol 2009, 40:631-8. 10.1016/j.humpath.2008.10.011, 19157502.
20. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 2004, 101:18123-8. 10.1073/pnas.0408273101, 539804, 15601761.
21. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 2001, 61:2212-9.
22. Dictenberg JB, Zimmerman W, Sparks CA, Young A, Vidair C, Zheng Y, Carrington W, Fay FS, Doxsey SJ. Pericentrin and gamma-tubulin form a protein complex and are organized into a novel lattice at the centrosome. J Cell Biol 1998, 141:163-74. 10.1083/jcb.141.1.163, 2132723, 9531556.
23. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol 1993, 3:255-68. 10.1111/j.1750-3639.1993.tb00752.x, 8293185.
24. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-29.
25. Lee WH, Yeh MY, Tu YC, Han SH, Wang YC. Establishment and characterization of a malignant glioma cell line, GBM8401/TSGH,NDMC. J Surg Oncol 1988, 38:173-81. 10.1002/jso.2930380309, 2839737.
26. Bignold LP, Coghlan BL, Jersmann HP. Hansemann, Boveri, chromosomes and the gametogenesis-related theories of tumours. Cell Biol Int 2006, 30:640-4. 10.1016/j.cellbi.2006.04.002, 16753311.
27. Friedlander M. Centrioles and centrospheres in giant cells of human gliomas. J Submicrosc Cytol 1982, 14:401-6.
28. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998, 58:3974-85.
29. Kollareddy M, Dzubak P, Zheleva D, Hajduch M. Aurora kinases: structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008, 152:27-33.
30. Keen N, Taylor S. Aurora-kinase inhibitors as anticancer agents. Nat Rev Cancer 2004, 4:927-36. 10.1038/nrc1502, 15573114.
31. Biggins S, Severin FF, Bhalla N, Sassoon I, Hyman AA, Murray AW. The conserved protein kinase Ipl1 regulates microtubule binding to kinetochores in budding yeast. Genes Dev 1999, 13:532-44. 10.1101/gad.13.5.532, 316509, 10072382.
32. Anand S, Penrhyn-Lowe S, Venkitaraman AR. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003, 3:51-62. 10.1016/S1535-6108(02)00235-0, 12559175.
33. Katayama H, Brinkley WR, Sen S. The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis 2003, 22:451-64.